Fundraise

2Eyes Vision raises €473,000 for ophthalmic tech in CDTI co-investment

What's the deal? 2Eyes VisionDealroom has a profile for this one. Try Dealroom →, a Madrid-based ophthalmic technology company, has raised an early-stage round with a €473,000 contribution from CDTIDealroom has a profile for this one. Try Dealroom → Innovación. The deal, announced in October, was co-invested alongside ACE 53 and Bullnet Capital IIIDealroom has a profile for this one. Try Dealroom → through Spain's state-backed Innvierte programme.

What does the company do? 2Eyes Vision develops technologies for vision diagnosis and correction. It is one of two healthcare-focused companies CDTI Innovación backed in October.

Why now? CDTI Innovación, the sole shareholder of Innvierte, completed two co-investment transactions last month totalling €833,000. The second went to Naru Intelligence Solutions, a Guipúzcoa-based firm building machine learning systems for biomedicine, which received €360,000 alongside Orza Gestión and Mondragón Fondo de Promoción.

What's the endgame? Innvierte supports venture capital investment in technology-based and innovative companies. It operates through a closed-ended investment vehicle supervised by the Spanish National Securities Market Commission.

The signal: Innvierte forms part of the Spanish Strategy for Science, Technology and Innovation 2021–2027, approved in September 2020. The programme is one of the pillars of the government's R&D policy, channelling public capital into deep-tech and healthtech startups that private investors back in parallel.

Read more: capital-riesgo.es

Image credit: Generated with Gemini

More top stories